Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 30, 2024 04:06 ET | Source: Research and Markets

COVID-19 Clinical Trials Market - Global Therapeutics, Vaccines, Phase I, Phase II, Phase III Forecast 2024-2030

Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Global COVID-19 Clinical Trials Market by Product (Therapeutics, Vaccines), Phase (Phase I, Phase II, Phase III) - Forecast 2024-2030" report has been...
September 01, 2023 11:33 ET | Source: Research and Markets

Navigating Trials in Crisis: A Comprehensive Look at Global COVID-19 and Long COVID Clinical Trials Amidst Disruptions

Dublin, Sept. 01, 2023 (GLOBE NEWSWIRE) -- The "Clinical Trials - Impact of COVID-19 and Long COVID" report has been added to ResearchAndMarkets.com's offering.This report provides an overview of...
August 08, 2023 06:28 ET | Source: Research and Markets

Global COVID-19 Clinical Trials Market Outlook 2023-2030 by Product, Phase, and Region with Insights Into Shares & Strategies of Key Players

Dublin, Aug. 08, 2023 (GLOBE NEWSWIRE) -- The "Global COVID-19 Clinical Trials Market Forecast 2023-2030" report has been added to ResearchAndMarkets.com's offering. The Global COVID-19 Clinical...
May 22, 2023 07:38 ET | Source: Research and Markets

2022 Clinical Trial Investigations Scorecard: Top Therapy Areas, Indications, Geographies and Sponsors

Dublin, May 22, 2023 (GLOBE NEWSWIRE) -- The "Clinical Trials Scorecard for Clinical Trial Investigations in 2022" report has been added to ResearchAndMarkets.com's offering.This report provides an...
September 09, 2022 07:03 ET | Source: Research and Markets

Global Clinical Trial Kits Market (2022 to 2030) - Featuring Almac, Alpha Laboratories and Brooks Life Science Among Others

Dublin, Sept. 09, 2022 (GLOBE NEWSWIRE) -- The "Clinical Trial Kits Market Share, Size, Trends, Industry Analysis Report, By Service , By Phase , By Region; Segment Forecast, 2022 - 2030" report has...
May 24, 2022 05:08 ET | Source: Research and Markets

Global Clinical Trial Management System (CTMS) Market Report 2022: A $2.75+ Billion Market by 2027 - Increasing Innovative Technology Developments to Reduce the Rising Cost of Clinical Trials

Dublin, May 24, 2022 (GLOBE NEWSWIRE) -- The "Global Clinical Trial Management System (CTMS) Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering. The...
May 13, 2022 06:58 ET | Source: Research and Markets

2022 Clinical Trials Analysis Report: Clinical Trials Planned to Initiate in 2022, Clinical Trials Estimated to Complete in 2022, Spotlight on COVID-19 Clinical Trials

Dublin, May 13, 2022 (GLOBE NEWSWIRE) -- The "Clinical Trials in 2022 - A Preview of Trials Planned to Initiate and Estimated to Complete in 2022" report has been added to ResearchAndMarkets.com's...
October 12, 2021 05:53 ET | Source: Research and Markets

Global Coronavirus Disease (COVID-19) Clinical Trials Report 2021: Overview of Trial Numbers and their Average Enrollment in Top Countries

Dublin, Oct. 12, 2021 (GLOBE NEWSWIRE) -- The "Coronavirus Disease 2019 (COVID-19) - Global Clinical Trials Review, H2, 2021" clinical trials has been added to ResearchAndMarkets.com's offering. The...
June 09, 2020 08:00 ET | Source: Tabula Rasa HealthCare, Inc.

Regence and TRHC partner on COVID-19 virtual clinical trial to assess proposed treatment risks

MOORESTOWN, N.J., June 09, 2020 (GLOBE NEWSWIRE) -- Regence and Tabula Rasa HealthCare® (NASDAQ: TRHC) announced today that the companies have partnered on a virtual clinical trial to assess the...
April 29, 2020 07:55 ET | Source: Tabula Rasa HealthCare, Inc.

TRHC Launches First Large Simulation Study to Assess Adverse Drug Events with proposed COVID-19 Treatments

MOORESTOWN, N.J., April 29, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare Corporation® (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announced today...